Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-299675
Filing Date
2026-07-09
Accepted
2026-07-09 16:05:28
Documents
16
Effectiveness Date
2026-07-09

Document Format Files

Seq Description Document Type Size
1 S-8 d10605ds8.htm S-8 33928
2 EX-5.1 d10605dex51.htm EX-5.1 11788
3 EX-23.1 d10605dex231.htm EX-23.1 1697
4 EX-99.1 d10605dex991.htm EX-99.1 93377
5 EX-FILING FEES d10605dexfilingfees.htm   iXBRL EX-FILING FEES 12356
6 GRAPHIC g10605dsp20.jpg GRAPHIC 4415
7 GRAPHIC g10605dsp21.jpg GRAPHIC 2690
  Complete submission text file 0001193125-26-299675.txt   282899

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d10605dexfilingfees_htm.xml XML 4820
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-297341 | Film No.: 261165736
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)